Ascendis Pharma
ASND
ASND
143 hedge funds and large institutions have $6.42B invested in Ascendis Pharma in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 14 closing their positions.
Holders
143
Holders Change
+14
Holders Change %
+10.85%
% of All Funds
2.82%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.3%
New
36
Increased
50
Reduced
46
Closed
14
Calls
$102M
Puts
$26.4M
Net Calls
+$75.3M
Net Calls Change
-$15.3M
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$68M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$82.5M |
| 3 |
O
3
OrbiMed
New York
|
$465M |
| 4 |
MWNA
4
Marshall Wace North America
New York
|
$65.6M |
| 5 |
FCM
5
Farallon Capital Management
San Francisco,
California
|
$178M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KAS
151
Kemnay Advisory Services
New York
| – | -$902K | -9,367 | Closed |
|
152
Simplex Trading
Chicago,
Illinois
| – | -$508K | -5,284 | Closed |
|
|
EGM
153
Engineers Gate Manager
New York
| – | -$433K | -4,491 | Closed |
|
|
DTL
154
Dynamic Technology Lab
Singapore
| – | -$430K | -4,469 | Closed |
|
|
SCM
155
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$298K | -3,090 | Closed |
|
|
QT
156
Quantbot Technologies
New York
| – | -$28K | -300 | Closed |
|
|
ASN
157
Advisory Services Network
Atlanta,
Georgia
| – | -$9K | -78 | Closed |
|